GLP1 agonists and risk of major adverse liver outcomes
Crossref DOI link: https://doi.org/10.1038/s41575-024-00911-6
Published Online: 2024-02-14
Published Print: 2024-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ray, Katrina
Text and Data Mining valid from 2024-02-14
Version of Record valid from 2024-02-14
Article History
First Online: 14 February 2024